European Medicines Agency recommended marketing authorisation for 16 medicines for the treatment of cancer in 2013

In 2013, the European Medicines Agency’s Committee for Medicinal Products for Human Use recommended 81 medicines for human use for marketing authorisation, compared with 57 in 2012. In 2013, 16 new medicines for the treatment of cancer were recommended for marketing authorisation, of which 12 contain a new active substance. Read more here.